BRIEF-Ionis Pharmaceuticals Q4 Revenue USD 227 Million Vs. IBES Estimate USD 137.6 Million

Reuters
19 Feb
BRIEF-Ionis Pharmaceuticals Q4 Revenue USD 227 Million Vs. IBES Estimate USD 137.6 Million

Feb 19 (Reuters) - Ionis Pharmaceuticals Q4 adjusted operating income USD -74 million vs. IBES estimate USD -176.5 million.

  • Q4 adjusted operating expenses USD 301 million
  • Q4 operating income USD -110 million
  • Q4 operating expenses USD 337 million

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10